[Community-acquired Pneumonia: Focus on Viral CAP]

Overview

Journal Rev Malad Respir Actual

Specialty Pulmonary Medicine

Date 2020 Apr 15

PMID 32288906

Authors

F Schlemmer

Affiliations

Soon will be listed here.

References

Melendi G, Laham F, Monsalvo A, Casellas J, Israele V, Polack N . Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics. 2007; 120(2):e410-5. DOI: 10.1542/peds.2006-3283. View

Lee N, Chan M, Lui G, Li R, Wong R, Yung I . High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus Infections. J Infect Dis. 2015; 212(8):1237-40. PMC: 7539363. DOI: 10.1093/infdis/jiv248. View

Niederman M . Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clin Infect Dis. 2008; 47 Suppl 3:S127-32. DOI: 10.1086/591393. View

Yende S, DAngelo G, Kellum J, Weissfeld L, Fine J, Welch R . Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med. 2008; 177(11):1242-7. PMC: 2720087. DOI: 10.1164/rccm.200712-1777OC. View

Gottlieb J, Zamora M, Hodges T, Musk A, Sommerwerk U, Dilling D . ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients. J Heart Lung Transplant. 2015; 35(2):213-21. DOI: 10.1016/j.healun.2015.08.012. View

Duncan C, Walsh E, Peterson D, Lee F, Falsey A . Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. J Infect Dis. 2009; 200(8):1242-6. PMC: 2896971. DOI: 10.1086/605948. View

Marcos P, Restrepo M, Sanjuan P, Ferreira-Gonzalez L, Verea-Hernando H . Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia. Hosp Pract (1995). 2013; 41(3):7-14. DOI: 10.3810/hp.2013.08.1063. View

Timbrook T, Maxam M, Bosso J . Antibiotic Discontinuation Rates Associated with Positive Respiratory Viral Panel and Low Procalcitonin Results in Proven or Suspected Respiratory Infections. Infect Dis Ther. 2015; 4(3):297-306. PMC: 4575297. DOI: 10.1007/s40121-015-0087-5. View

DeVincenzo J, Whitley R, Mackman R, Scaglioni-Weinlich C, Harrison L, Farrell E . Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med. 2014; 371(8):711-22. DOI: 10.1056/NEJMoa1401184. View

10.

Musher D, Bebko S, Roig I . Serum procalcitonin level, viral polymerase chain reaction analysis, and lower respiratory tract infection. J Infect Dis. 2013; 209(4):631-3. DOI: 10.1093/infdis/jit579. View

11.

Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

12.

Falsey A, Formica M, Hennessey P, Criddle M, Sullender W, Walsh E . Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173(6):639-43. PMC: 2662947. DOI: 10.1164/rccm.200510-1681OC. View

13.

DeVincenzo J, McClure M, Symons J, Fathi H, Westland C, Chanda S . Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study. N Engl J Med. 2015; 373(21):2048-58. DOI: 10.1056/NEJMoa1413275. View

14.

Corrales-Medina V, Alvarez K, Weissfeld L, Angus D, Chirinos J, Chang C . Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015; 313(3):264-74. PMC: 4687729. DOI: 10.1001/jama.2014.18229. View

15.

Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber P . Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006; 174(1):84-93. DOI: 10.1164/rccm.200512-1922OC. View

16.

Fuller H, Del Mar C . Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev. 2006; (4):CD004883. DOI: 10.1002/14651858.CD004883.pub2. View

17.

Self W, Williams D, Zhu Y, Ampofo K, Pavia A, Chappell J . Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis. 2015; 213(4):584-91. PMC: 4721902. DOI: 10.1093/infdis/jiv323. View

18.

Gilbert D . Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis. 2011; 52 Suppl 4:S346-50. DOI: 10.1093/cid/cir050. View

19.

Ramilo O, Lagos R, Saez-Llorens X, Suzich J, Wang C, Jensen K . Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness. Pediatr Infect Dis J. 2013; 33(7):703-9. DOI: 10.1097/INF.0000000000000240. View

20.

El-Solh A, Vora H, Knight 3rd P, Porhomayon J . Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes. Crit Care Med. 2011; 39(6):1251-6. PMC: 3102149. DOI: 10.1097/CCM.0b013e31820a942c. View